NCT07135466 2026-01-16
A Phase 1/2 Study of T-cell Expressing an Anti-CD22 Chimeric-Antigen Receptor (SHB-04-CD22) in Patients With CD22-expressing B-cell Malignancies
Sheba Medical Center
Phase 1/2 Recruiting
Clinical Trials
7 trialsNCT06409767 2025-09-24
ALHERT
University Hospital, Angers
Phase NA Recruiting
NCT06026046 2025-09-19
EscrimHEMA
University Hospital, Angers
Phase NA Active not recruiting
NCT06944119 2025-07-28
Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia
Tel-Aviv Sourasky Medical Center
Active not recruiting
NCT06795815 2025-06-12
OHGW-ACP
Azienda USL Reggio Emilia - IRCCS
Phase NA Recruiting
NCT06964841 2025-05-09
PRIMARY TESTICULAR LYMPHOMA
Instituto Mexicano del Seguro Social
Completed
NCT04263935 2025-04-23
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Henan Cancer Hospital
Recruiting